Literature DB >> 7708953

The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity.

A M Moody1, W P Mayles, J M Bliss, R P A'Hern, J R Owen, J Regan, B Broad, J R Yarnold.   

Abstract

A prospective assessment of late changes in breast appearance in 559 patients after tumour excision and radiotherapy for early breast cancer noted a strong association with breast size. Only 3/48 (6%) patients with small breasts developed moderate or severe late changes compared with 94/423 (22%) with medium sized breasts and 34/88 (39%) patients with large breasts (p < 0.001). One possibility is that greater radiation changes are related to greater dose inhomogeneity in women with large breasts. To explore this hypothesis, radiation dose distributions were assessed in a separate group of 37 women in whom three-level transverse computer tomographic images of the breast in the treatment position were available. A significant correlation was found between breast size and dose inhomogeneity which may account for the marked changes in breast appearance reported in women with large breasts.

Entities:  

Mesh:

Year:  1994        PMID: 7708953     DOI: 10.1016/0167-8140(94)90063-9

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  52 in total

Review 1.  Recent developments in breast-conserving surgery for breast cancer patients.

Authors:  F Fitzal; O Riedl; R Jakesz
Journal:  Langenbecks Arch Surg       Date:  2008-09-10       Impact factor: 3.445

2.  Irregular surface compensation for radiotherapy of the breast: correlating depth of the compensation surface with breast size and resultant dose distribution.

Authors:  D J Emmens; H V James
Journal:  Br J Radiol       Date:  2009-09-14       Impact factor: 3.039

3.  Dosimetric evaluation of whole breast radiotherapy using field-in-field technique in early-stage breast cancer.

Authors:  Masahiro Sasaoka; Tomoyuki Futami
Journal:  Int J Clin Oncol       Date:  2011-01-14       Impact factor: 3.402

4.  Field-in-field IMRT versus 3D-CRT of the breast. Cardiac vessels, ipsilateral lung, and contralateral breast absorbed doses in patients with left-sided lumpectomy: a dosimetric comparison.

Authors:  Duygu Baycan; Didem Karacetin; Ayben Y Balkanay; Yücel Barut
Journal:  Jpn J Radiol       Date:  2012-09-19       Impact factor: 2.374

5.  Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO/ÖGRO).

Authors:  F Sedlmayer; M L Sautter-Bihl; W Budach; J Dunst; P Feyer; R Fietkau; W Haase; W Harms; C Rödel; R Souchon; F Wenz; R Sauer
Journal:  Strahlenther Onkol       Date:  2013-03       Impact factor: 3.621

6.  Cosmetic outcome 1-5 years after breast conservative surgery, irradiation and systemic therapy.

Authors:  Gyöngyi Kelemen; Zoltán Varga; György Lázár; László Thurzó; Zsuzsanna Kahán
Journal:  Pathol Oncol Res       Date:  2011-10-08       Impact factor: 3.201

7.  Partial-volume segmentation for dose optimization in whole-breast radiotherapy: a comparative dosimetric and clinical analysis.

Authors:  Elisabeth Tromm; Andreas Meyer; Jörg Frühauf; Michael Bremer
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

8.  Radiation induced apoptosis and initial DNA damage are inversely related in locally advanced breast cancer patients.

Authors:  Beatriz Pinar; Luis Alberto Henríquez-Hernández; Pedro C Lara; Elisa Bordon; Carlos Rodriguez-Gallego; Marta Lloret; Maria Isabel Nuñez; Mariano Ruiz De Almodovar
Journal:  Radiat Oncol       Date:  2010-09-24       Impact factor: 3.481

9.  Breast dose heterogeneity in CT-based radiotherapy treatment planning.

Authors:  R Prabhakar; G K Rath; P K Julka; T Ganesh; R C Joshi; N Manoharan
Journal:  J Med Phys       Date:  2008-04

10.  Different intensity extension methods and their impact on entrance dose in breast radiotherapy: A study.

Authors:  A Sankar; J Velmurugan
Journal:  J Med Phys       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.